- Home
- AUPH vs AOD Comparison
AUPH vs AOD Comparison
Compare AUPH & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- AOD
- Stock Information
- Founded
- AUPH 1993
- AOD 2006
- Country
- AUPH Canada
- AOD United States
- Employees
- AUPH N/A
- AOD N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- AOD Investment Managers
- Sector
- AUPH Health Care
- AOD Finance
- Exchange
- AUPH Nasdaq
- AOD Nasdaq
- Market Cap
- AUPH 1.1B
- AOD 934.1M
- IPO Year
- AUPH 1999
- AOD N/A
- Fundamental
- Price
- AUPH $7.93
- AOD $8.71
- Analyst Decision
- AUPH Strong Buy
- AOD
- Analyst Count
- AUPH 3
- AOD 0
- Target Price
- AUPH $10.33
- AOD N/A
- AVG Volume (30 Days)
- AUPH 1.0M
- AOD 301.9K
- Earning Date
- AUPH 02-27-2025
- AOD 01-01-0001
- Dividend Yield
- AUPH N/A
- AOD 8.43%
- EPS Growth
- AUPH N/A
- AOD N/A
- EPS
- AUPH N/A
- AOD N/A
- Revenue
- AUPH $220,361,000.00
- AOD N/A
- Revenue This Year
- AUPH $36.97
- AOD N/A
- Revenue Next Year
- AUPH $16.43
- AOD N/A
- P/E Ratio
- AUPH N/A
- AOD N/A
- Revenue Growth
- AUPH 38.72
- AOD N/A
- 52 Week Low
- AUPH $4.71
- AOD $7.02
- 52 Week High
- AUPH $10.67
- AOD $8.45
- Technical
- Relative Strength Index (RSI)
- AUPH 47.47
- AOD 50.44
- Support Level
- AUPH $7.50
- AOD $8.63
- Resistance Level
- AUPH $8.12
- AOD $8.90
- Average True Range (ATR)
- AUPH 0.27
- AOD 0.07
- MACD
- AUPH 0.02
- AOD 0.01
- Stochastic Oscillator
- AUPH 53.49
- AOD 55.24
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.